logo
Share SHARE
FONT-SIZE Plus   Neg

Tech Mahindra Forays Into Higher Education Sector

Tech Mahindra Ltd. said the Mahindra Group marked its entry into the higher education sector with the inauguration of a premier Engineering institution - Mahindra Ecole Centrale (MEC) in collaboration with Ecole Centrale Paris, the 200-year-old French university, and Jawaharlal Nehru Technological University (JNTU), Hyderabad, a premier institution with academic and research oriented courses.

Mahindra Ecole Centrale is the maiden venture of Mahindra Educational Institutions, a subsidiary of Tech Mahindra. The campus would come up at the Bahadurpally site of the company where it has huge stretch of land.

Tech Mahindra's Executive Vice-Chairman Vineet Nayyar said, "We recognize the critical need to transform engineering talent into business leadership, in a globalized world. Mahindra Ecole Centrale will provide apprenticeship with collaboration from the industry focus on humanities, international exposure and allied education to develop a 'whole-brain-approach' to business."

Mahindra Ecole Centrale will be based on a modern and international academic programme that "blends basic scientific and technical education with contemporary industry practices", Nayyar said.

"Our integrated curriculum will develop students with the unique ability to adapt to global engineering challenges and new technologies that will shape our future and also to master the complexity of multinational organizations," he added.

At the BSE, Tech Mahindra shares are currently trading at Rs.1,336, up 3.37 percent from the previous close.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

More Breaking News

0 Articles
Editors Pick
Goldman Sachs downgraded the rating of retailer Target Corp. Thursday to sell from neutral over concerns about its increasing competition with e-commerce giant Amazon.com Inc. Target's price target was reduced to $67 from $77. It is expected that the retailer's efforts to compete with Amazon will result in sluggish sales and profits. Catabasis' phase II trial of Edasalonexent in boys affected by Duchenne muscular dystrophy is ongoing, and top-line results are anticipated in the first half of Q1 2017. American Express Co. (AXP) Thursday reported a drop in fourth-quarter profit, as revenues declined 4 percent due to absence of Costco portfolio while provisions for bad loans and marketing costs increased. Earnings fell short of Wall Street estimates, while revenues trumped expectations. New York-based...
comments powered by Disqus
Follow RTT